Meadow Creek Investment Management’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$25K Hold
1,652
﹤0.01% 1307
2019
Q2
$33K Sell
1,652
-1,512
-48% -$25.1K ﹤0.01% 1302
2019
Q1
$53K Hold
3,164
﹤0.01% 1267
2018
Q4
$44K Sell
3,164
-27,636
-90% -$366K ﹤0.01% 1225
2018
Q3
$539K Buy
30,800
+1,372
+5% +$26.3K 0.01% 694
2018
Q2
$536K Sell
29,428
-2,632
-8% -$44.6K 0.01% 621
2018
Q1
$601K Buy
+32,060
New +$624K 0.01% 580

Other funds holding KURA

Meadow Creek Investment Management's KURA Position: Q3 2019 in Review

Meadow Creek Investment Management held its Kura Oncology (KURA) position steady in Q3 2019 at 1,652 shares worth $25K. The position accounts for ﹤0.01% of the portfolio, ranked #1307.

Meadow Creek Investment Management first reported a position in KURA in Q1 2018 and has held it in 7 quarters since. The position peaked at $601K in Q1 2018. 116 funds tracked by Wall St. Rank hold KURA as of Q3 2019.

  • Meadow Creek Investment Management held 1,652 shares of Kura Oncology worth $25K as of Q3 2019.
  • Meadow Creek Investment Management left its Kura Oncology share count unchanged in Q3 2019.
  • Kura Oncology made up ﹤0.01% of Meadow Creek Investment Management's portfolio in Q3 2019, its #1307 holding.
  • Meadow Creek Investment Management first reported a position in Kura Oncology in Q1 2018 and has held it in 7 quarters since.
  • Meadow Creek Investment Management's Kura Oncology position peaked at $601K in Q1 2018.
  • 116 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2019.

Based on Meadow Creek Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.